FDA Announces New Domestic-Manufacturing-Focused Pilot Program

The current administration continues efforts to boost domestic manufacturing.

One of President Trump’s stated goals across all industry has been a desire to reduce the United State’s dependence on imported goods. While he has targeted a wide swath of industries, he has specifically targeted the pharmaceutical industry.

This is most likely due to this particular issue playing a key role in another of the President’s initiatives, reducing the cost of pharmaceuticals in the United States.

On February 1, FDA announced a new pilot program designed to promote the construction of domestic manufacturing sites, along with increasing regulatory predictability and and streamlining manufacturing facility assessments.1

FDA PreCheck will begin in 2026 and include a group of domestic facilities that the agency says are aligned with national priorities. The criteria used to decide this will be:

• Products to be manufactured
• Phase of facility development
• Timeline to producing products to US market
• Innovation in facility development

Also, any facility developing critical medications for the US market will be considered for the initial group.

In a statement FDA Commissioner Marty Makary, MD, MPH, said, “After 35 years of globalists taking pharmaceutical manufacturing overseas, the FDA is taking bold steps to bring it back. The PreCheck program is one of several powerful incentives we are providing to make the U.S. pharmaceutical manufacturing sector more resilient and competitive.”

This is just the latest effort by FDA to promote domestic manufacturing and reduce dependence on imports.

In late January, the agency announced the results of the ImportShield Program, which aims to bring consistent oversight to the import review process across the entire country.2 In order to achieve this, the existing five regional teams were restructured into just one centralized team.

According to FDA, this resulted in:

• An increase to processing speed by 66%
• An increase to monthly volume capacity by 33%
• A reduction in staff hours by 20%

In a press release, Makary said, “Whether it’s detecting counterfeit medications or identifying contaminated food products, the FDA ImportShield Program and other modernization efforts add a powerful new layer of protection for American families.”

Meanwhile, major pharmaceutical companies have been announcing major manufacturing projects within the United States.

The latest example of this is Eli Lilly, who just announced plans to invest $3.5 billion in a manufacturing facility in Lehigh Valley, Pennsylvania.3 The site will focus on injectal medicine and device manufacturing. The site should be operational by 2031.

In a press release, Lilly chair and CEO David A. Ricks said, “”Our mission starts with patients and delivering the medicines they need. To meet increasing demand, we’re expanding our U.S. manufacturing network, with Lehigh Valley adding capacity for next‑generation weight-loss medicines. We’re creating high‑quality jobs and collaborating across the region—with suppliers, educators, and workforce‑development partners—to make critical medicines in the U.S. That’s our commitment—to patients, to our new Pennsylvania home and to our country.”

In the same press release, Pennsylvania Governor Josh Shapiro said, “”When we announced our Economic Development Strategy here in the Lehigh Valley two years ago, we set out to win historic, life-changing deals like the one we’re announcing with Lilly today. Before I took office, Pennsylvania wasn’t even in the conversation for major investments like this, but thanks to our work to cut red tape, invest in site development, and expand our workforce, our Commonwealth is now competing—and winning—on a national scale. Lilly’s commitment to the Lehigh Valley and to Pennsylvania will bring billions of dollars of investment and hundreds of good-paying jobs, solidifying our position as a leader in the growing life sciences industry.”

Sources

1. FDA Launches PreCheck Pilot Program to Strengthen Domestic Pharmaceutical Manufacturing. FDA. February 1, 2026. https://www.fda.gov/news-events/press-announcements/fda-launches-precheck-pilot-program-strengthen-domestic-pharmaceutical-manufacturing
2. FDA ImportShield Program Delivers Impressive Results in Strengthening FDA Oversight at U.S. Ports of Entry. FDA. January 21, 2026. https://www.fda.gov/news-events/press-announcements/fda-importshield-program-delivers-impressive-results-strengthening-fda-oversight-us-ports-entry
3. Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility. Eli Lilly. January 30, 2026. https://investor.lilly.com/news-releases/news-release-details/lilly-selects-pennsylvania-home-its-newest-injectable-medicine

Source link

John Deere Announces Two New U.S. Facilities, Expands American Manufacturing

MOLINE, Ill. — John Deere announced plans to expand its U.S. manufacturing footprint with the opening of two new domestic facilities, reinforcing the company’s long-standing commitment to American industry, innovation, and job creation. The expansion includes a new distribution center near Hebron, Indiana, and a state-of-the-art excavator factory in Kernersville, North Carolina, both expected to open within the next year.

The investment reflects John Deere’s broader strategy to strengthen its U.S.-based supply chain while relocating key manufacturing operations from overseas to domestic campuses. Notably, the Kernersville facility will produce the only excavator designed, developed, and manufactured entirely in the United States.

Courtesy: Photo by John Deere“Our investment in these new facilities underscores John Deere’s dedication to strengthening the backbone of American industry and supporting local economies,” said John May, chairman and chief executive officer of John Deere. “We believe in building America, and these projects represent our intent to continue driving innovation and job creation in the United States.“

Indiana Expansion Strengthens Supply Chain

John Deere recently broke ground on its new distribution center near Hebron, Indiana, a location chosen for its central position and strong workforce. The facility is designed to enhance nationwide supply chain operations, ensuring faster and more reliable delivery of equipment and parts across multiple customer segments.

The Indiana project is expected to create approximately 150 jobs and support John Deere customers across agriculture, turf, construction, forestry, and mining markets.

“This new facility is an investment in customer expectations around world class product support through parts availability for our US based ag, turf, construction, forestry, mining and turf customers,” said Denver Caldwell, vice president, Aftermarket and Customer Support. “Indiana’s strong workforce and central location make it an ideal choice for expansion.”

John Deere will continue operating its primary North American Parts Distribution Center in Milan, Illinois, which has been in service since 1973 and employs approximately 1,200 workers.

Courtesy: Photo by John Kakuk on Unsplash

Kernersville Factory Brings Excavator Production Home

In North Carolina, John Deere will invest $70 million to construct a new excavator factory at its Kernersville campus. The facility will leverage advanced manufacturing technologies to produce next-generation excavators for the construction market and will take over production previously based in Japan.

The new factory is expected to employ more than 150 people and play a key role in meeting growing equipment demand while reinforcing domestic manufacturing capabilities.

“We are excited to bring this new facility to our Kernersville campus and to be part of the region’s thriving manufacturing community,“ said Ryan Campbell, president Worldwide Construction and Forestry and Power Systems. “Our focus will be on delivering excellence, creating jobs, and advancing the legacy of John Deere in American manufacturing.”

Long-Term Commitment to U.S. Manufacturing

Company leadership emphasized that the two new facilities are part of a broader, long-term investment strategy aimed at strengthening U.S. manufacturing capacity and economic growth.

“These investments further demonstrate our commitment to invest $20B in U.S. manufacturing over the next 10 years,” May said. “It is a testament to our confidence in the future of U.S. manufacturing and our unwavering commitment to innovation, quality, and economic growth.”

With these projects, John Deere is expected to create hundreds of new American jobs while expanding its ability to serve customers and support local economies across the Midwest and Southeast.

Originally reported by Deere.Com

Source link

John Deere Announces Major Expansion With Two New United States Facilities : CEG

In keeping with its tradition of building America, John Deere announced plans to open two new U.S.-based facilities: a distribution center near Hebron, Ind., and an excavator factory in Kernersville, N.C., both set to open in the next year.

“Our investment in these new facilities underscores John Deere’s dedication to strengthening the backbone of American industry and supporting local economies,” said John May, chairman and chief executive officer of John Deere. “We believe in building America, and these projects represent our intent to continue driving innovation and job creation in the United States.”

New Distribution Center in Ind.

John Deere recently broke ground on a new distribution center near Hebron, Ind., located to enhance its supply chain capabilities nationwide, according to the company. This facility will be designed to streamline operations and ensure timely delivery of equipment and parts. The Indiana project is anticipated to generate employment opportunities with approximately 150 jobs, contributing to the state’s economic growth.

“This new facility is an investment in customer expectations around world class product support through parts availability for our US based ag, turf, construction, forestry, mining and turf customers,” said Denver Caldwell, vice president of aftermarket and customer support. “Indiana’s strong workforce and central location make it an ideal choice for expansion.”

John Deere will continue to maintain its primary North American parts distribution center in Milan, Ill., which has been in operation since 1973 and employs approximately 1,200 people.

Kernersville, N.C. Excavator Factory

The new $70 million factory in Kernersville, N.C., will bolster John Deere’s manufacturing capabilities, leveraging new technology to produce excavators for the construction market. The North Carolina factory will assume production of future generation excavators previously produced in Japan.

This facility will employ more than 150 people and will help meet equipment demand and strengthen the company’s commitment to manufacturing within the United States.

“We are excited to bring this new facility to our Kernersville campus and to be part of the region’s thriving manufacturing community,” said Ryan Campbell, president of worldwide construction, forestry and power systems. “Our focus will be on delivering excellence, creating jobs and advancing the legacy of John Deere in American manufacturing.”

Building America

With the opening of these two facilities, John Deere will create hundreds of new jobs in the United States, further supporting local communities and advancing our mission to build a stronger America.

“These investments further demonstrate our commitment to invest $20 billion in U.S. manufacturing over the next 10 years,” May said. “It is a testament to our confidence in the future of U.S. manufacturing and our unwavering commitment to innovation, quality and economic growth.”

For more information, visit deere.com/en/.

Source link

John Deere Announces Major Expansion with Two New U.S. Facilities Coming

Expansion builds on Deere’s and President Trump’s Commitment to U.S. Manufacturing

What it means:

• NEW American Jobs
• The Kernersville Campus moved Manufacturing / Production from Overseas (Japan) to America
• The Kernersville campus will produce the ONLY excavator designed, developed, and manufactured in the U.S.

In keeping with our strong tradition of building America, we are excited to announce plans to open two new U.S.-based facilities: a state-of-the-art distribution center near Hebron, Indiana, and a cutting-edge excavator factory in Kernersville, North Carolina, both set to open in the next year.

“Our investment in these new facilities underscores John Deere’s dedication to strengthening the backbone of American industry and supporting local economies,” said John May, chairman and chief executive officer of John Deere. “We believe in building America, and these projects represent our intent to continue driving innovation and job creation in the United States.“

Expanding in Indiana: New Distribution Center

John Deere recently broke ground on a new distribution center near Hebron, Indiana, strategically located to enhance our supply chain capabilities nationwide. This facility will be designed to streamline operations and ensure timely delivery of equipment and parts. The Indiana project is anticipated to generate significant employment opportunities with approximately 150 jobs, contributing to the state’s economic growth.

“This new facility is an investment in customer expectations around world class product support through parts availability for our US based ag, turf, construction, forestry, mining and turf customers,” said Denver Caldwell, vice president, Aftermarket and Customer Support. “Indiana’s strong workforce and central location make it an ideal choice for expansion.”

John Deere will continue to maintain its primary North American Parts Distribution Center in Milan, Illinois, which has been in operation since 1973 and employs about 1,200 people.

Kernersville, North Carolina: New Excavator Factory

The new $70M factory in Kernersville, North Carolina, will bolster John Deere’s manufacturing capabilities, leveraging advanced technologies to produce industry leading excavators for the construction market. The North Carolina factory will assume production of future generation excavators previously produced in Japan.

This facility will employ over 150 people and will help meet equipment demand and strengthen our commitment to U.S. manufacturing innovation.

“We are excited to bring this new facility to our Kernersville campus and to be part of the region’s thriving manufacturing community,“ said Ryan Campbell, president Worldwide Construction and Forestry and Power Systems. “Our focus will be on delivering excellence, creating jobs, and advancing the legacy of John Deere in American manufacturing.”

Building America: Impact and Commitment

With the opening of these two facilities, John Deere will create hundreds of new U.S. jobs, further supporting local communities and advancing our mission to build a stronger America.

“These investments further demonstrate our commitment to invest $20B in U.S. manufacturing over the next 10 years,” May said. “It is a testament to our confidence in the future of U.S. manufacturing and our unwavering commitment to innovation, quality, and economic growth.”

About Deere & Company

It doesn’t matter if you’ve never driven a tractor, mowed a lawn, or operated a dozer. With John Deere’s role in helping produce food, fiber, fuel, and infrastructure, we work for every single person on the planet. It all started nearly 200 years ago with a steel plow. Today, John Deere drives innovation in agriculture, construction, forestry, turf, power systems, and more.

For more information on Deere & Company, visit us at www.deere.com/en/news/.

Media contact:

Jen Hartmann

publicrelations@johndeere.com

Source link

Meta Announces Up to $6 Billion Agreement With Corning to Support US Manufacturing

Building and operating data centers – the infrastructure that brings our technologies to life and supports our goal of personalized superintelligence – requires strong servers and hardware that connect and transfer information in near real time. Fiber optic cables are a critical part of supplying this connectivity, helping us power everything from wearable technology like Ray-Ban Meta AI glasses to our apps, which connect billions of people and businesses around the world.

Today, we’re announcing an up to $6 billion multi-year partnership with Corning that will supply fiber optic cables for our data center infrastructure. This agreement enables Corning to expand its manufacturing operations in North Carolina and add new jobs in the state.

“Building the most advanced data centers in the US requires world-class partners and American manufacturing. We’re proud to partner with Corning – a company with deep expertise in optical connectivity and commitment to domestic manufacturing – for the high-performance fiber optic cables our AI infrastructure needs. This collaboration will help create good-paying, skilled US jobs, strengthen local economies, and help secure the US lead in the global AI race.”

– Joel Kaplan, Chief Global Affairs Officer, Meta

As part of this agreement, Corning will grow its manufacturing capabilities across its operations, which includes a significant capacity expansion at the Trivium Corporate Center in Catawba County, North Carolina.

“This long-term partnership with Meta reflects Corning’s commitment to develop, innovate, and manufacture the critical technologies that power next generation data centers here in the US,” said Wendell P. Weeks, Chairman and Chief Executive Officer of Corning Incorporated. “The investment will expand our manufacturing footprint in North Carolina, support an increase in Corning’s employment levels in the state by 15 to 20 percent, and help sustain a highly skilled workforce of more than 5,000, including the scientists, engineers, and production teams at two of the world’s largest optical fiber and cable manufacturing facilities. Together with Meta, we’re strengthening domestic supply chains and helping ensure that advanced data centers are built using US innovation and advanced manufacturing.”

Meta’s data centers – 26 of which are under construction or operational in the US – have already supported 30,000 skilled trade jobs during construction and support 5,000 operational jobs. This includes electricians, HVAC specialists, server and network technicians, safety and security experts, and engineers who work together to run some of the world’s most advanced facilities.

As digital tools and generative AI continue to transform our economy – in fields like healthcare, finance, agriculture, and more – the demand for fiber connectivity will continue to grow. By supporting American companies like Corning and building and operating data centers in America, we’re helping ensure that our nation maintains its competitive edge in the digital economy and the global race for AI leadership.

Source link

BD announces $110m U.S. manufacturing investment

BD (Becton, Dickinson and Company), a leading global medical technology company, has announced a $110m investment to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery and supporting pharmaceutical reshoring in the U.S.

This investment will bring BD Neopak™ Glass Prefillable Syringe production to Columbus, Nebraska, creating approximately 120 new jobs and reinforcing the company’s supply resilience within its Pharmaceutical Systems portfolio.

“This is good news for Nebraska,” said Sen. Ricketts. “It has the potential to bring over 100 new jobs to our state. This investment further underscores BD’s ongoing commitment to keep critical manufacturing in states like Nebraska. I appreciate BD’s long-standing partnership with the Cornhusker State.”

The BD Neopak™ Glass Prefillable Syringe platform is purpose-built to meet the complex and evolving needs of biologics and combination products development. Available in 1 mL and 2.25 mL formats, the BD Neopak™ Glass Prefillable Syringe supports a wide range of formulation requirements, including high viscosity, drug-container compatibility, and integration with delivery devices. It is designed for seamless integration with autoinjectors, enabling flexible, patient-centric drug delivery in both clinical and at-home settings.

“As demand for biologics and GLP-1s accelerates, BD is strengthening its American manufacturing footprint to support U.S.-based drug delivery innovation and supply chain resiliency,” said Patrick Jeukenne, worldwide president of BD Pharmaceutical Systems. “This investment in Nebraska, advances our long-term growth strategy and reflects our commitment to partnering with biopharmaceutical innovators as they bring advanced therapies to patients who require next-generation drug delivery solutions.”

Strategic Investments in Columbus, Nebraska

BD is investing $100m to establish BD Neopak™ Glass Prefillable Syringe production at its Columbus site, with supply expected to begin in mid-2026. This investment will also support additional line upgrades and capacity improvements across the site, ensuring BD can meet growing global demand for advanced injectable solutions. In addition, BD is investing $10m to enhance cannula manufacturing capabilities at the site, and together these investments will add approximately 120 new jobs.

This announcement builds on BD’s recent investment of more than $35m to expand prefilled flush syringe manufacturing in Columbus, which will add approximately 50 new jobs and strengthen the supply of critical medical devices to health care providers across the U.S. BD Columbus has been a strategic site within BD’s global manufacturing network for more than 75 years and is home to part of the company’s vertically integrated cannula manufacturing operations, including design and production. As the largest medical device manufacturer in the United States, these investments are part of BD’s commitment to invest more than $2.5bn in U.S. manufacturing capabilities over the next five years.

Strengthening U.S. Supply Chain Resilience

This expansion underscores the company’s commitment to building a more resilient and responsive pharmaceutical supply chain in the United States. By localizing production of the BD Neopak™ Glass Prefillable Syringe platform, BD is helping to ensure continuity, scalability, and speed to market for life-changing injectable therapies – especially as demand rises for biologics and combination products used to treat chronic and high-burden diseases.

As the global leader in biologics drug delivery, BD continues to invest in innovation and infrastructure to meet current needs and ensure that patients everywhere can benefit from the therapies of tomorrow.

Source link